
Call Us: 269-430-7966
🎉 Detroit Opens June 15 — Now booking consultations for opening week. Reserve your spot →
When parents start looking into treatments for autism spectrum disorder (ASD), they often run into unfamiliar terms: folate metabolism, MTHFR gene variants, and folinic acid. The real question behind all of it is simpler: How can I best help my child?
This post is a plain-language overview. For a deeper look at the science, see our full Leucovorin and Autism page.
Important: Leucovorin is not appropriate for every child, and we never offer it as a stand-alone treatment at Brain Treatment Center Michigan.
These three sound alike, but the body treats them very differently. The distinction matters most for children with an MTHFR gene variant or folate receptor alpha autoantibodies (FRAAs) — both can make it harder for the brain to use folate.
For some children with ASD, Leucovorin makes folate available to the brain when genetics or immune-related issues are getting in the way.
Folate plays a quiet but critical role in brain development and function. It supports:
When folate can’t reach the brain effectively, the result is called cerebral folate deficiency (CFD). Research has connected CFD to challenges with speech, thinking, attention, and emotional regulation in some children with autism.
Every autism evaluation at Brain Treatment Center Michigan starts with a qEEG (quantitative EEG) — a gentle, painless scan that measures electrical activity in the brain. It helps us see patterns that may relate to communication, mood, or overall brain function.
Recent research found a distinct 4.5-Hz brainwave rhythm in some children with autism. In one study, 80% of children with this pattern carried one or both MTHFR variants, with findings consistent across diverse backgrounds. That means a qEEG can sometimes flag children who are more likely to benefit from folate-based support — without the stress of a blood draw.
MeRT® is a personalized form of repetitive Transcranial Magnetic Stimulation (rTMS). Instead of a one-size-fits-all protocol, MeRT uses your child’s qEEG to guide treatment. Our doctors and neuroscientists review the report, then build a stimulation plan tailored to your child’s unique brain activity.
If your child’s evaluation suggests folate-processing differences, our physician may recommend L-methylfolate or, in select cases, Leucovorin. Leucovorin is never used alone at our clinic.
Think of folate as fuel. MeRT helps the brain communicate and synchronize more effectively — but the brain still needs the right fuel to make the most of that work. Pairing Leucovorin with MeRT addresses both sides: the biochemistry and the brain activity.
In March 2026, the FDA approved Leucovorin for cerebral folate deficiency (CFD) — the first approved treatment for that condition. The FDA did not approve Leucovorin specifically for autism.
That distinction matters. Research suggests some children with autism also have CFD or other folate-processing differences, and those are the children most likely to benefit from folinic acid support. A qEEG and clinical evaluation help us identify whether your child may fall into that group.
No. Leucovorin is not a cure, and autism is not something we frame as needing a cure.
For some children with documented folate-processing differences, families have reported improvements in communication, language, attention, and motor regulation. When paired with MeRT, our aim is measurable progress in daily functioning.
If you’re exploring Leucovorin for autism or wondering whether your child may have folate-processing differences, the first step is a qEEG and initial evaluation. Call us at 269-430-7966 to schedule.
Scientific interest in folate metabolism and autism has grown significantly over the last decade.





